Novo Nordisk Annual Report 2021
Financial statements of the parent company
Novo Nordisk Annual Report 2021 98
Financial statements of the parent company 2021
The following pages comprise the financial statements of the parent company, the legal entity Novo Nordisk A/S. Apart from ownership of the subsidiaries in the Novo Nordisk Group, activity within the parent company mainly comprises
sales, research and development, production, corporate activities and support functions.
Income statement
Balance sheet
For the year ended 31 December
At 31 December
DKK million
Note
2021
2020
DKK million
Note
2021
2020
DKK million.
Note
2021
2020
Net sales
2
Cost of goods sold
3
Gross profit
Sales and distribution costs
3
112,553
(26,642)
85,911
(30,021)
100,940
(20,662)
Assets
Equity and liabilities
Intangible assets
6
9,110
7,938
Share capital
462
470
80,278
Property, plant and equipment
7
27,007
25,322
Net revaluation reserve according to
the equity method
17,675
9,749
(26,673)
Financial assets
8
71,564
43,598
Development costs reserve
1,218
959
Research and development costs
3
(15,244)
(14,524)
Deferred income tax assets
5
228
Reserve for cash flow hedge
(1,600)
1,617
Administrative costs
3
(1,976)
(1,913)
Other receivables and prepayments
218
Retained earnings
52,714
50,241
Other operating income and
Total non-current assets
expenses
1,032
1,976
Raw materials
107,909
3,754
77,076
Total equity
70,469
63,036
2,781
Operating profit
39,702
39,144
Borrowings
10
10,111
596
Work in progress
10,899
10,647
Profit in subsidiaries, net of tax
8
16,879
10,394
Deferred income tax liabilities
5
523
Finished goods
2,131
2,246
Financial income
4
2,415
2,144
Other provisions
11
1,377
1,348
Inventories
16,784
15,674
Financial expenses
4
(2,225)
(2,238)
Total non-current liabilities
11,488
2,467
Trade receivables
2,128
1,523
Profit before income taxes
56,771
49,444
Borrowings
10
12,648
6,275
Amounts owed by affiliated companies
13,200
15,893
Income taxes
(9,248)
(7,285)
Derivative financial instruments
9
2,184
1,365
Tax receivables
695
Net profit
47,523
42,159
Trade payables
3,048
2,910
Other receivables and prepayments
2,967
2,353
Receivables
18,990
19,769
Amounts owed to affiliated
companies
53,826
40,931
Marketable securities
5,904
Tax payables
171
3,114
Derivative financial instruments
9
1,690
2,332
Other liabilities
6,313
6,262
Cash at bank
8,870
11,509
Total current liabilities
78,190
60,857
Total current assets
Total assets
52,238
160,147
49,284
Total liabilities
89,678
63,324
126,360
Total equity and liabilities
160,147
126,360View entire presentation